Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M115Revenue $M3.5Net Margin (%)28.5Altman Z-Score1.1
Enterprise Value $M83.5EPS $-0.5Operating Margin %28.8Piotroski F-Score7
P/E(ttm)17.8Beneish M-Score1.9Pre-tax Margin (%)28.8Higher ROA y-yY
Price/Book4.010-y EBITDA Growth Rate %--Quick Ratio14.9Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %--Current Ratio14.9Lower Leverage y-yY
Price/Free Cash Flow11.4y-y EBITDA Growth Rate %--ROA % (ttm)22.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)29.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.4ROIC % (ttm)469Gross Margin Increase y-yN

Gurus Latest Trades with PSDV

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

PSDV is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


PSDV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ashton PaulPresident & CEO 2014-10-01Sell10,000$4.27-8.2 view
Ashton PaulPresident & CEO 2014-09-02Sell10,000$4.78-17.99 view
Ashton PaulPresident & CEO 2014-08-01Sell10,000$4.37-10.3 view
Ashton PaulPresident & CEO 2014-07-01Sell10,000$4.32-9.26 view
Ashton PaulPresident & CEO 2014-06-19Sell7,000$4-2 view
Freedman LoriVP Corp. Affairs, GC and Sec 2014-06-17Sell7,900$4-2 view
Ashton PaulPresident & CEO 2014-06-17Sell7,700$4-2 view
Ashton PaulPresident & CEO 2014-06-13Sell11,800$4.02-2.49 view
Freedman LoriVP Corp. Affairs, GC and Sec 2014-06-13Sell11,700$4.02-2.49 view
Freedman LoriVP Corp. Affairs, GC and Sec 2014-05-05Sell3,500$4.01-2.24 view

Press Releases about PSDV :

    Quarterly/Annual Reports about PSDV:

    News about PSDV:

    Articles On GuruFocus.com
    pSivida Ltd. Reports Operating Results (10-Q) Feb 10 2011 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 09 2010 
    pSivida Ltd. Reports Operating Results (10-K) Sep 27 2010 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 12 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 13 2009 
    pSivida Ltd. Reports Operating Results (10-K) Sep 25 2009 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2009 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 11 2009 
    pSivida Corp. Reports Results for the Second Quarter Ended December 31, 2008; Iluvien™ NDA filing Feb 11 2009 

    More From Other Websites
    pSivida Reports Positive IOP Safety Data in Phase III Trial of Medidur™ for Posterior Uveitis May 19 2015
    pSivida Reports Positive IOP Safety Data in Phase III Trial of Medidur™ for Posterior Uveitis May 19 2015
    PSIVIDA CORP. Financials May 15 2015
    pSivida Announces Two Tech Evaluation Agreements with Leading Global Pharmaceutical Company May 12 2015
    pSivida Announces Two Tech Evaluation Agreements with Leading Global Pharmaceutical Company May 12 2015
    pSivida Announces Two Tech Evaluation Agreements with Leading Global Pharmaceutical Company May 12 2015
    10-Q for pSivida Corp. May 10 2015
    pSivida Corp Earnings Call scheduled for 8:30 am ET today May 08 2015
    pSivida Corp. Reports Third Quarter FY 2015 Results May 08 2015
    PSivida reports 3Q loss May 08 2015
    PSivida reports 3Q loss May 08 2015
    PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 08 2015
    pSivida Corp. Reports Third Quarter FY 2015 Results May 08 2015
    Q3 2015 pSivida Corp Earnings Release - Before Market Open May 08 2015
    pSivida Corp. Announces Third Quarter Fiscal Year 2015 Financial Results Release Date and Conference... May 01 2015
    pSivida Corp. Announces Third Quarter Fiscal Year 2015 Financial Results Release Date and Conference... May 01 2015
    pSivida Corp. Reports ILUVIEN® for DME Approved in Poland Apr 18 2015
    pSivida Corp. Reports ILUVIEN® for DME Approved in Poland Apr 14 2015
    pSivida Corp. Reports ILUVIEN® for DME Approved in Poland Apr 14 2015
    pSivida Corp. Reports ILUVIEN® for DME Approved in Poland Apr 14 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK